140 related articles for article (PubMed ID: 15721498)
21. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM
Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915
[TBL] [Abstract][Full Text] [Related]
22. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
23. INTERMACS: interval analysis of registry data.
Holman WL; Pae WE; Teutenberg JJ; Acker MA; Naftel DC; Sun BC; Milano CA; Kirklin JK
J Am Coll Surg; 2009 May; 208(5):755-61; discussion 761-2. PubMed ID: 19476831
[TBL] [Abstract][Full Text] [Related]
24. Levosimendan reversing low output syndrome after heart transplantation.
Petäjä LM; Sipponen JT; Hämmäinen PJ; Eriksson HI; Salmenperä MT; Suojaranta-Ylinen RT
Ann Thorac Surg; 2006 Oct; 82(4):1529-31. PubMed ID: 16996977
[TBL] [Abstract][Full Text] [Related]
25. Sodium nitroprusside for advanced low-output heart failure.
Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
[TBL] [Abstract][Full Text] [Related]
26. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.
Schenk S; McCarthy PM; Blackstone EH; Feng J; Starling RC; Navia JL; Zhou L; Hoercher KJ; Smedira NG; Fukamachi K
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):447-54. PubMed ID: 16434277
[TBL] [Abstract][Full Text] [Related]
27. Heart failure: epidemiologic update.
Hodges P
Crit Care Nurs Q; 2009; 32(1):24-32. PubMed ID: 19077806
[TBL] [Abstract][Full Text] [Related]
28. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005.
Lietz K; Miller LW
J Am Coll Cardiol; 2007 Sep; 50(13):1282-90. PubMed ID: 17888847
[TBL] [Abstract][Full Text] [Related]
29. Inotropes in the management of acute heart failure.
Petersen JW; Felker GM
Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469
[TBL] [Abstract][Full Text] [Related]
30. [End-stage heart failure: quantity or quality of life?].
Delahaye F; Mercusot A; Carra L; Gouton M
Arch Mal Coeur Vaiss; 2005 Mar; 98(3):186-91. PubMed ID: 15816320
[TBL] [Abstract][Full Text] [Related]
31. Rationale and design of the enoximone clinical trials program.
Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
[TBL] [Abstract][Full Text] [Related]
32. A bridge for the 21st century in heart transplantation?
Felker GM; O'connor CM
Am Heart J; 2003 Feb; 145(2):198-9. PubMed ID: 12595831
[No Abstract] [Full Text] [Related]
33. The next treatment option: using ventricular assist devices for heart failure.
Stahovich M; Chillcott S; Dembitsky WP
Crit Care Nurs Q; 2007; 30(4):337-46. PubMed ID: 17873570
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus.
Fieno DS; Czer LS; Schwarz ER; Simsir S
Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):919-20. PubMed ID: 19706718
[TBL] [Abstract][Full Text] [Related]
35. Heart transplantation in insulin-treated diabetic mellitus patients with diabetes-related complications.
Ikeda Y; Tenderich G; Zittermann A; Minami K; Koerfer R
Transpl Int; 2007 Jun; 20(6):528-33. PubMed ID: 17403108
[TBL] [Abstract][Full Text] [Related]
36. Levitronix as a short-term salvage treatment for primary graft failure after heart transplantation.
Santise G; Petrou M; Pepper JR; Dreyfus G; Khaghani A; Birks EJ
J Heart Lung Transplant; 2006 May; 25(5):495-8. PubMed ID: 16678025
[TBL] [Abstract][Full Text] [Related]
37. Pharmacy Support of a Pediatric Patient Receiving Milrinone at Home.
Xue A; Dersch-Mills D; Tsang C; Greenway SC
Can J Hosp Pharm; 2016; 69(5):415-419. PubMed ID: 27826160
[No Abstract] [Full Text] [Related]
38. Ventricular assist device therapy.
Sayer G; Naka Y; Jorde UP
Cardiovasc Ther; 2009; 27(2):140-50. PubMed ID: 19426251
[TBL] [Abstract][Full Text] [Related]
39. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
40. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
